ScienceDaily (Sep. 23, 2008) -- Extended treatment with Alzheimer's disease drugs can significantly slow the rate at which the disorder advances, and combination therapy with two different classes of

March 3, 2009. Memantine is marketed for moderate-to-severe Alzheimer's, but two recent studies suggest it is effective for all stages of the disease when used in combination with any one of the olde